Navigation Links
Liquid biomaterials take stem cell therapy to new level
Date:3/17/2011

At present, cartilage implants created using stem cells can only be constructed as a solid shape, acting as an interim measure before the almost inevitable need for total joint replacement.

Now researchers at the University of Bristol are investigating the possibilities of a biologically-engineered synthetic liquid polymer that would eliminate the need for further surgery by offering a one stop, permanent solution.

Dr Wael Kafienah, from Bristol's School of Medical Sciences, believes this research could represent the next breakthrough in stem cell therapy. He and his team are collaborating with researchers in Canada and Qatar to explore how such a biomaterial could be created. Dr Kafienah, the lead Principal Investigator for Bristol, has been funded by the Qatar National Research Fund (QNRP), with approximately $1 million over a period of three years to conduct the initial research. The QNRP has an international annual cycle of highly competitive, peer-reviewed, collaborative funding.

If the research proves successful, clinical trials could be carried out within five years.

Initial research shows that an injectable gel would have the capacity to form three-dimensional scaffolds that could be moulded to assume the solid form of even an irregularly shaped defected area, resulting in the formation of new tissue that would fully fill the defect at the point of delivery and encourage the growth of healthy cells.

A gel-based biomaterial could also be used for immunotherapy, where stem cells injected into the body would stimulate the immune system to destroy the tumour by providing a source of gene therapies or therapeutic vaccines. Injecting these stem cells in the form of a gel would allow clinicians to target the tumour through a prolonged, controlled release of the therapeutic proteins required, with obvious benefits to the patient as there would be fewer courses of treatment.

Dr Kafienah said: "The ve
'/>"/>

Contact: Aliya Mughal
aliya.mughal@bristol.ac.uk
44-117-331-7033
University of Bristol
Source:Eurekalert

Page: 1 2

Related medicine news :

1. A new high-resolution method for imaging below the skin using a liquid lens
2. Leading Electronic Cigarette Manufacturer Vapure Announces U.S. Made E-Liquid
3. Announcing NutriVite, Liquid Multivitamin Shots - Welcome to the Future of Vitamins
4. GMP Labs Expands Liquid Nutraceutical Capabilities
5. New Liquid Functional Nutrition Products: EYL Beverages Announces Debut of DeCOMPRESS™ and Debug™ Beverages at Natural Products EXPO West
6. Liquid Love: Last Minute Valentines Day Gift For Your Heart
7. New therapy found for rare lung disorder
8. Sirolimus therapy alleviates symptoms of lung disease LAM
9. Research study explores gene therapy treatment to reduce symptoms of Parkinsons disease
10. University Hospitals Case Medical Center testing innovative heat therapy for premature ejaculation
11. Ohio State study: Targeted ovarian cancer therapy not cost-effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Birth Boot Camp , a ... have over 130 certified instructors in more than 30 ... addition, the company recently launched a new doula ... certification program . Birth Boot Camp is unique because ... The practical information can be used by the couple ...
(Date:3/3/2015)... PLAINSBORO, N.J. (PRWEB) March 03, 2015 ... Simon Cancer Center have joined forces to share ... OncLive announced today. The collaboration is part of ... the new alliance, OncLive’s editorial and marketing teams ... a National Cancer Institute-designated cancer center, to highlight ...
(Date:3/3/2015)... Charleston, SC (PRWEB) March 03, 2015 March ... Collins for the 200th episode. The episode was a unique ... the fourth season, but because it featured two men who ... a car accident. At the beginning of the episode, Deierlein ... several times on my radio show, but I’m very excited ...
(Date:3/3/2015)... Celestix Networks, the leading provider ... the global availability of Celestix Cloud Edge Security ... most deployed platform for DirectAccess and remote access ... new release enables organizations to manage the Windows® ... single HTML 5 web interface called Comet 2.0. ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
Breaking Medicine News(10 mins):Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2
... beat has a basic rhythm in which it beats. The ... is a sustained heart rhythm abnormality,// medical advice is immediately ... to time, in other words a missed heart beat, or ... a lack of co-ordination of the electrical activity which keeps ...
... out of Switzerland finds children who are exposed to greater ... asthma or allergies. Researchers had parents of children ages 7 ... They also took blood samples from the kids to test ... from the children's bedding to test for levels of endotoxin, ...
... procurable in the doctor's office or the drugstore to test ... of the Government Chemist) have been working to produce a ... and produces results within 15 to 20 minutes. ... shoebox for ease of use in doctors' offices or drugstores. ...
... the treatment naltrexone is effective among those with a ... distinguish two patterns of drinking// - the Anglo-Saxon/Scandinavian pattern, ... the weekend and holidays, and the Mediterranean pattern, where ... The Anglo-Saxon pattern has been linked most often with ...
... for cancer has mostly been very beneficial to patients.Around six ... have a clear genetic cause. And we now know// at ... them. Dr.Lindsay Prior, a sociologist at Cardiff University felt that ... be advised to have the test. The reasons are technical, ...
... to a new study a clot-buster injection may unclog ... Rothenburger, M.D., researcher from University Hospital in Germany,// ... very serious problem for heart failure patients who receive ... device is a mechanical pump-like device that is surgically ...
Cached Medicine News:
(Date:3/3/2015)... , March 3, 2015  Delcath Systems, Inc. ... and medical device company focused on oncology with ... metastatic liver cancers, announces that the results from ... in 2009, have been submitted for publication in ... utilized Melphalan Hydrochloride for Injection for use with ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of SNS Research,s new report ... - Opportunities, Challenges, Strategies & Forecasts" to ... drug is a pharmaceutical product, usually intended to ... manufactured without a license from the innovator company ...
(Date:3/3/2015)... 2015 Mapi incorporates the expertise ... the drug development and commercialization process. ... Regulatory services with the addition of the CanReg Group, ... . CanReg is one of North America,s ... affairs for life sciences companies. With nearly 100 consultants, ...
Breaking Medicine Technology:Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 2Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 3Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 5Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 6Mapi incorporates Strategic Regulatory Services to support life-science product Commercialization and Health Research 2
... TT™ offers the ultimate research level wireless ... knowledgeable clinician and researcher today. Offering superb ... to meet your desired footprint requirements. Choose ... display live data both in the room ...
... expectations with state of the art software ... to meet the needs of your busy ... be upgraded to grow with you. With ... management, it is easy to see why ...
... offers ultimate flexibility by allowing you to ... and display. Wall-mount anywhere in the room. ... a laptop, touch screen tablet, industrial PC, ... this multi-function patient tower provides more power ...
... Advanced diagnostic capabilities combined with ease ... best product in its class. Ideal for ... a complete system for Uroflowmetry, cystometry, leak ... (8) configurations are available which make the ...
Medicine Products: